Evidence map›Paper›PMID 33146921›Full record

ArticleJournal of veterinary internal medicine2020

Effect of prednisolone therapy on serum levels of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester lipase in dogs.

Beatriz Mendoza, Maria Joana Dias, Telmo Nunes, Maria Alexandra Basso, Juan Hernandez, Rodolfo Oliveira Leal

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Advances in the diagnosis of acute pancreatitis in dogs.Journal of veterinary internal medicine · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Beatriz MendozaFaculdade de Medicina Veterinária, Universidade de Lisboa, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-1083-0118
Maria Joana DiasFaculdade de Medicina Veterinária, Universidade de Lisboa, Lisbon, Portugal.
Telmo NunesFaculdade de Medicina Veterinária, Universidade de Lisboa, Lisbon, Portugal.
Maria Alexandra BassoFaculdade de Medicina Veterinária, Universidade de Lisboa, Lisbon, Portugal.
Juan HernandezInternal Medicine Service, ONIRIS, Ecole Nationale Vétérinaire, Nantes, France.
Rodolfo Oliveira LealFaculdade de Medicina Veterinária, Universidade de Lisboa, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-2463-4062
University of Lisbon · PTOniris · FR

Funding

Centro de Investigação Interdisciplinar em Sanidade Animal - Faculdade de Medicina Veterinária - Universidade de Lisboa UIDB/00276/2020 (funded by FCT)
6 · The paper itself

Abstract

backgroundActivity of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase in serum shows good agreement with pancreatic lipase (cPL) in dogs. Although prednisolone therapy does not seem to affect serum cPL concentration, its influence on DGGR lipase is unclear.

objectivesThe aim of the study was to evaluate the effect of prednisolone therapy on DGGR lipase serum activity in dogs. ANIMALS: Thirty-four dogs were used, of which 17 dogs received prednisolone (study group) and 17 healthy dogs did not receive treatment.

methodsA prospective cohort study measured DGGR lipase activity in both groups at 3 time points: T0, T1, and T2, corresponding to days 0, 7-10, and 21-30, respectively. Dogs from study group presented a medical reason that justified the use of prednisolone for at least 3 weeks. Initial prednisolone dose was .5-2.0 mg/kg/day PO with a reduction at T1 to a final dose that was maintained until T2. DGGR lipase activity >160 U/L was defined as clinically relevant.

resultsIn the study group, DGGR lipase activity increased significantly from T0 to T1 (P = .02) and decreased significantly from T1 to T2 (P = .02). Median DGGR activity at each time point (T0, T1, and T2) was 24.74 (14.45-31.48), 36.82 (23.8-80.16), and 29.52 (15.91-48.48) U/L, respectively. In the control group, no significant changes were observed over time (P = .93). The DGGR lipase activity and prednisolone doses were not correlated for both T0-T1 (r CONCLUSION AND CLINICAL IMPORTANCE: DGGR lipase activity was affected by prednisolone administered orally in dogs. However, this variation was not clinically important as values remained below the relevant upper limit.

Indexed as

Dog DiseasesPancreatitisAnimalsDogsEstersGlutaratesLipasePrednisoloneProspective StudiesEstersGlutaratesglutaric acidLipasePrednisolonecorticosteroidsdoglaboratory diagnosispancreatitis

Identifiers

PMID33146921
PMCPMC7694796
OpenAlexW3097365267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.